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http://dx.doi.org/10.1016/j.jmii.2013Background/Purpose(s): In Taiwan, clinical and microbiological data on acute otitis media
(AOM) with spontaneous otorrhea in children are limited.
Methods: We retrospectively collected data on children with AOM and spontaneous otorrhea
between January 2011 and June 2012. Otorrhea samples were collected using sterile swabs
and sent for cultures. Pathogens found were Streptococcus pneumoniae, Haemophilus influen-
zae, Moraxella catarrhalis, Streptococcus pyogenes, and Staphylococcus aureus. Pneumo-
coccal isolates collected from October 2011 to June 2012 were serotyped.
Results: A total of 92 patients were enrolled in the study for demographic and microbiological
analysis. Their median age was 2.5 years. After excluding those with lobar pneumonia, 84 pa-
tients were included for analysis of clinical manifestation. The mean febrile duration was 6
days. Leukocytosis and C-reactive protein (CRP) level >50 mg/L were noted in 29 (34.5%) pa-
tients and 38 (45.2%) patients, respectively. Patients with pneumococcal infection were older
(p Z 0.007) and had more severe symptoms [fever (p Z 0.001), otalgia (p Z 0.055), respira-
tory symptoms (p Z 0.002e0.03), and higher CRP level (p Z 0.015)] than children with other
bacterial infection. Otorrhea cultures were obtained from 69 (75%) patients, of whom 52 had
definitive AOM pathogens. The most common causative pathogen was S. pneumoniae (61.5%),
followed by S. aureus (36.5%). Serotype 19A accounted for two-thirds of pneumococcal isolates
and had a high rate of nonsusceptibility to penicillin (66.7%) and ceftriaxone (83.3%).of Pediatrics, Chang Gung Children’s Hospital, Number 5, Fu-Hsin Street, Kweishan 333, Taoyuan,
.org.tw (C.-H. Chiu).
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Acute otitis media with spontaneous otorrhea 383Conclusion: S. pneumoniae was found to be the most important source of AOM with sponta-
neous otorrhea in children and caused more severe symptoms. Serotype 19A, which was usually
nonsusceptible to antimicrobial agents, was the most prevalent serotype in these patients.
Copyright ª 2013, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Acute otitis media (AOM) is a common disease in children,
and more than 80% of them experience at least one episode
of AOM prior to the age of 3 years.1 The incidence of AOM in
Taiwan was reported to be 64.6 cases per 1000 children (33.5
cases per 100 person-years) and mostly noted in children
aged 0e2 years.2 A variety of studies have found that spon-
taneous otorrhea is one of the complications of AOM that
occurs in 3.3e52% of children with AOM.3e5 Given the diffi-
culty in obtaining children’s cooperation for performing
tympanocentesis, spontaneous otorrhea provides an easier
way to approach the etiology of AOM. In addition to the well-
known pathogens such as Streptococcus pneumoniae, Hae-
mophilus influenzae, Moraxella catarrhalis, Streptococcus
pyogenes, and Staphylococcus aureus was also reported to
cause spontaneous otorrhea.6,7 Chiu et al8 reported the
epidemiological and microbiological characteristics of
culture-proven AOM in children of northern Taiwan during
1999e2008, but the serotype data of pneumococcus and data
from other hospitals in Taiwan were lacking. Since October
2005, pneumococcal conjugate vaccination (PCV) has been
introduced in Taiwan in the private sector. The aim of this
study is to analyze the demographics and microbiology,
including pneumococcal serotype distribution and antibiotic
susceptibility, of patients having AOM and spontaneous
otorrhea during January 2011eJune 2012 in northern Taiwan.
Materials and methods
Patients
This study was conducted in a 395-bed children hospital in
northern Taiwan. The study was approved by the Institu-
tional Review Board of Chang Gung Memorial Hospital. Pe-
diatric inpatients younger than 18 years admitted during
January 2011eJune 2012 were enrolled in the study. A total
of 738 inpatients were diagnosed with AOM, based on the
International Classification of Diseases, ninth version,
Clinical Modification (ICD-9-CM) code 3810, 3820, or 3829.
Repeated cases and patients with chronic otitis media,
tympanostomy tube insertion, immunodeficiency, malig-
nancy, and other chronic illness were excluded. Ninety-two
patients with spontaneous otorrhea were enrolled for de-
mographic studies and pathogen analysis. Detailed clinical
features were obtained from 84 patients after excluding
eight patients having necrotizing or lobar pneumonia.
Microbiology
Samples of middle ear fluid was obtained from the ear canal
using sterile swabs (Copan sterile plain swabs; Copan Italia,Brescia, Italy) either within 24 hours after otorrhea was
diagnosed or within 24 hours after admission. The swabs
were then transported to the laboratory in Amies transport
medium (Copan Italia, Brescia, Italy), and placed on blood
agar whole plate, eosin methylene blue (EMB) whole plate,
and Columbia colistin-nalidixic acid (CNA) agar biplate, and
cultured at 37C for 48 hours. Pathogens causing AOM were
identified as S. pneumoniae, H. influenzae, M. catarrhalis,
S. pyogenes, and S. aureus. Patients with positive S.
pneumoniae isolates (including those with mixed infection)
were categorized as the pneumococcal group and the
others as the non-pneumococcal group.
Between October 2011 and June 2012, pneumococcal
isolates from swabcultureswere collected, subcultured, and
frozen at e70C. Serogroups were determined by the latex
agglutination method (Pneumotest-latex; Statens Serum
Institute, Copenhagen, Denmark). The capsular swelling
method (Quellung reaction) was then performed using anti-
sera (Pneumococcal factor antisera; Statens Serum Institute)
for pneumococcal serotyping. Minimum inhibitory concen-
trations (MICs) of penicillin and ceftriaxonewere determined
by E test (AB Biodisk, Solona, Sweden), and susceptibility of
vancomycin, levofloxacin, and moxifloxacin was determined
by the disc diffusionmethod. The susceptibility criteria were
developed according to the Clinical and Laboratory Stan-
dards Institute (CLSI) guidelines.9 The CLSI nonmeningitis
criteria for penicillin susceptibility are defined as follows:
susceptible, MIC 2 mg/mL; intermediately resistant,
MIC Z 4 mg/mL; and resistant, MIC 8 mg/mL. The non-
meningitis criteria for ceftriaxone susceptibility are as fol-
lows: susceptible, MIC 1 mg/mL; intermediately resistant,
MICZ 2 mg/mL; and resistant, MIC 4 mg/mL.Definition
The diagnosis of AOM was made by a pediatrician or an
otolaryngologist. The diagnosis of acute mastoiditis was made
clinically or radiologically. Patients with mastoiditis may have
fever, otalgia or irritability, retroauricular pain, swelling, er-
ythema,andadownwardandoutwarddeviationof theauricle.
Coalescence or clouding of mastoid air cells is noted in plain
radiographs. In computed tomography (CT), the typical find-
ings includehazinessordestructionofmastoidoutline,and loss
of or decrease in the sharpness of bony septa.10 Thedurationof
four seasons were defined as follows: spring, MarcheMay;
summer, JuneeAugust; fall, SeptembereNovember; and
winter, DecembereFebruary. Analyses of pneumococcal con-
jugate vaccination [any PCV: 7-valent PCV (PCV7), 10-valent
PCV (PCV10), or 13-valent PCV (PCV13)] categorized patients
into those without vaccination and those receiving 1 dose.
Previousantibioticusewasdefinedasexposure toantibiotics in
the last2weeksprior toadmission.Leukocytosiswasdefinedas
white blood cell (WBC) count 15,000/mL.
Figure 1. Monthly distribution of inpatients with spontaneous otorrhea.
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For categorical variable, we used Chi-square test and
Fisher’s exact test, and the independent t test was used for
continuous variables. Statistical significance was defined as
p < 0.05 (2-sided). All analysis were performed using the
software SPSS, version 17.0 (SPSS Inc., Chicago, IL, USA).
Results
Epidemiology
A total of 100 inpatients had spontaneous otorrhea during
the study period. Fig. 1 shows the monthly distribution of
these episodes, and the ratios of the number of sponta-
neous otorrhea to the number of all-cause admissions (total
25,741 cases) and AOM admissions (total 738 cases). Peaks
were observed in January 2012 (28.7% to AOM admission
and 5.7& to all-cause admission) and January 2011 (21.7%
and 6.3&, respectively). Spontaneous otorrhea occurred
more frequently in autumn (17.16% to AOM admission and
5.8& to all-cause admission) and winter (18.1% and 4.9&,
respectively) compared to spring and summer (10e11.1%
and 2.3e3.3&, respectively).
Among 92 patients undergoing demographic analysis, the
median age was 2.5 years. Fifty-two percent of them were
2e5 years old, and 35% were less than 2 years. The male-to-
female ratio was 1.5. Eleven patients (12%) had previous
episodes of AOM. Among 90 patients with available history
of pneumococcal vaccination, 29 (32%) had 1 dose of any
type of PCV, and only three received 1 dose of PCV13.
Recent antibiotic exposure was reported in 37% of patients.
Clinical manifestations
After excluding those with lobar pneumonia, 84 patients
were enrolled in the study for analysis of clinical manifes-
tations and laboratory data (Table 1). Seventy-four patients
(88.1%) had fever, with a median duration of 6 days (range,1e20 days). Spontaneous otorrhea occurred at a median of
4 days following fever (range, e6 to 16 days). The median
duration of hospitalization was 5 days. In only one-quarter
of patients, bilateral ears were involved. Leukocytosis and
high C-reactive protein (CRP) level (>50 mg/L) were noted
in 34.5% and 45.2% of patients, respectively. Eight patients
(9.5%) had complications. Three had pneumococcal
bacteremia, two mastoiditis, one mastoiditis with choles-
teatoma, and the remaining two periauricular cellulitis.
Microbiology
Among the 92 inpatients with spontaneous otorrhea, 69
(75%) had otorrhea cultures, and 52 were found to be
culture positive (Table 2). S. pneumoniae accounted for
61.5% of all pathogens, followed by S. aureus (36.5%),
S. pyogenes (3.8%), M. catarrhalis (1.9%), and H. influenzae
(1.9%). Mixed infections were observed in five patients
(9.6%): S. pneumoniae plus S. aureus in three, S. pneu-
moniae plus H. influenza in one, and S. aureus plus
S. pyogenes in one. Other bacteria isolated from these
patients included the following: four Propionibacterium
acnes, two Klebsiella pneumoniae, two viridans stre-
ptococci, two Acinetobacter baumannii, two Peptos-
treptococcus spp., two Corynebacterium spp., one
Pseudomonas aeruginosa, and one b-hemolytic strepto-
coccus (group non-ABD). Among the 32 S. pneumoniae
isolates, 10 (31.3%) were intermediately resistant and one
(3.1%) was highly resistant to penicillin. Furthermore, 27
(84.3%) were intermediately resistant and two (6.3%) highly
resistant to ceftriaxone. All isolates were susceptible to
vancomycin, levofloxacin, and moxifloxacin.
We collected 28 isolates of S. pneumoniae from patients
with spontaneous otorrhea for serotyping: 16 specimens
from inpatients and 12 from outpatients. Serotypes 19A and
19F accounted for 64.3% (18/28) and 25% (7/28) of isolates,
respectively (Fig. 2). As to the antibiotic susceptibility of
serotype 19A, 11 (61.1%) were intermediately resistant and
one (5.6%) was highly resistant to penicillin, and 15 (83.3%)
were intermediately resistant and none was highly resistant
Table 2 AOM pathogens isolated from 52 children with
spontaneous otorrhea
Bacteria Isolate n (%)
Streptococcus pneumoniae 32 (61.5)
Streptococcus pyogenes 2 (3.8)
Moraxella catarrhalis 1 (1.9)
Haemophilus influenzae 1 (1.9)
Methicillin-resistant Staphylococcus aureus 12 (23.1)
Methicillin-sensitive S. aureus 7 (13.5)
Mixed infection 5 (9.6)
S. pneumoniae þ S. aureus 3
S. pneumoniae þ H. influenzae 1
S. aureus þ S. pyogenes 1
AOM Z acute otitis media.
Figure 2. Serotype distribution of Streptococcus pneumo-
niae isolated from 28 patients with spontaneous otorrhea.
Table 1 Clinical manifestations of the 84 patients with
spontaneous otorrhea
Case no. %
Symptoms and signs
Fever 74 88.1
Highest temperature (C) 39.41  0.65
Fever duration (d) 6  0.3.3
Otorrhea onset following fever (d) 4.34  3.51
Ear pain/ear rubbing 49 58.3
Cough 65 77.4
Rhinorrhea/nasal obstruction 60 71.4
Nausea/vomiting 8 9.5
Diarrhea 7 8.3
Unilateral 63 75
Laboratory data
Peak WBC (1000/mL) 14.09  5.34
Segment (%) 57.37  17.17
Lymphocyte (%) 31.24  14.58
Band (%) 0.51  1.35
Leukocytosis (WBC 15,000/mL) 29 34.5
Peak CRP (n Z 83, mg/L) 62.99  56.6
High CRP (>50 mg/L) 38 45.2
Associated diagnosis
Upper respiratory tract 14 16.7
Flu/flu-like illness 5 6
Sinusitis 10 11.9
Lower respiratory tracta 15 17.9
Acute gastroenteritis 6 7.1
Febrile convulsion 2 2.4
Complications 8 9.5
Mastoiditisb 3 3.6
Bacteremia 3 3.6
Periauricular cellulitis 2 2.4
Hospitalization duration (d) 4.95  2.28
a Lobar pneumonia and necrotizing pneumonia have been
excluded.
b One had concomitant cholesteatoma.
Data presented as mean  SD unless otherwise stated.
CRP Z C-reactive protein; SD Z standard deviation;
WBC Z white blood cell.
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comycin, levofloxacin, and moxifloxacin.
Comparison between AOM caused by
S. pneumoniae and other pathogens
The comparison of demographic characteristics is listed in
Table 3. The two groups were similar with respect to male
gender, underlying diseases, previous AOM history, antibi-
otic exposure, siblings, and pneumococcal vaccination
status. The median age of the nonpneumococcal group was
less than that of the pneumococcal group, but it did not
reach statistical significance. Classification of these pa-
tients into three age groups (0e2 years, 2e5 years, and >5
years) revealed that half of the cases from the pneumo-
coccal group were between 2 and 5 years of age, whereas
77.8% of patients from the nonpneumococcal group were
less than 2 years old (p Z 0.007).
As to the comparison of clinical manifestations between
the two groups (Table 4), all patients in the pneumococcal
group but only 61% of those in the nonpneumococcal group
had fever (p Z 0.001). Otalgia or ear rubbing was noted in
more patients in the pneumococcal group (62% vs. 33%), but
only equivocally significant difference was found
(p Z 0.055). Respiratory tract infection symptoms (cough
and rhinorrhea/nasal obstruction) were statistically more
common in the pneumococcal group, and bilateral otorrhea
occurred in 44.8% of them, compared to 5.6% in the non-
pneumococcal group (p Z 0.004). However, there was no
significant difference in the peak temperature, fever
duration, and otorrhea onset date following fever between
the two groups. Moreover, peak CRP level was significantly
higher in the pneumococcal group (p Z 0.015). No differ-
ence was observed when comparing complications and
hospitalization duration between the two groups.
Discussion
To our knowledge, only a few studies have discussed AOM
pathogens and pneumococcal serotypes in recent years in
Table 3 Comparison of demographics between patients
with pneumococcal infection and others
Pneumococcal
group (n Z 32)
Nonpneumococcal
group (n Z 18)
p
Male 18 (56.3) 12 (66.7) 0.470
Age
Mean  SD
(y/o)
2.92  2.16 1.96  2.92 0.189
Median
(range)
2.45
(0.58e12.25)
0.83
(0.13e10.42)
0e2 y old 12 (37.5) 14 (77.8) 0.007
2e5 y old 18 (56.3) 2 (11.1)
>5 y old 2 (6.3) 2 (11.1)
Underlying
disease
4 (12.5) 1 (5.6) 0.642
Previous AOM 2 (6.3) 1 (5.6) 1.000
Pneumococcal vaccination
Any PCVa 13/31 (41.9) 7/18 (38.9) 0.834
Any PCV7b 9/27 3/15 0.485
Any PCV13b 0/27 2/15 0.122
With sibling 18 (56.3) 10 (55.6) 0.962
Previous
antibiotic use
14/26 (53.8) 5/17 (29.4) 0.115
a Any PCV: patients having 1 dose of pneumococcal conju-
gate vaccine; data of pneumococcal vaccination were available
for 31 patients and 18 patients, respectively.
b PCV7, PCV13: seven-valent and 13-valent pneumococcal
conjugate vaccine; data available for 27 patients and 15 pa-
tients. None of them received 10-valent pneumococcal conju-
gate vaccine.
Data are presented as n (%) unless otherwise stated.
AOM Z acute otitis media; PCV Z pneumococcus conjugate
vaccination; SD Z standard deviation.
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often in winter months.11 The age of AOM peaks between 6
months and 18 months of age.12 However, in this study the
median age of spontaneous otorrhea was older (median 2.5
years, approximately half between 2 years and 5 years of
age). Approximately three-quarters (52 cases) of the pa-
tients were defined as culture positive. Patients with
pneumococcal infection were older and had more severe
symptoms (fever, otalgia, bilateral ear involvement, and
higher CRP level in more patients). Pneumococcal infection
accounted for the majority (two-thirds) of the causative
pathogens, and the most common serotype was 19A with
high antibiotic resistance.
In the current study, the most common pathogens in
spontaneous otorrhea were found to be S. pneumoniae and
S. aureus. Some earlier studies suggested that only
four well-known pathogens, including S. pneumoniae, M.
catarrhalis, H. influenzae, and S. pyogenes, cause otor-
rhea; meanwhile, S. aureus was thought to be only a con-
taminant.8,13e15 S. aureus is more related to chronic otitis
media, but its role in AOM is still unknown.16 Heslop and
Ovesen17 recovered S. aureus from 8e21% of cases with
acute ear infections (AOM, mastoidismus, and acute
mastoiditis). In recent years, AOM caused by methicillin-
resistant S. aureus have been reported.18,19 Brook and
Gober20 compared otorrhea specimens from spontaneousdraining AOM and those from aspiration of the remaining
middle ear effusion; they found that S. aureus did exist in
aspirate specimens and S. pneumoniae, S. pyogenes, and S.
aureus were predominant in otorrhea specimens. In a sub-
sequent study, S. aureus, including methicillin-resistant S.
aureus, was found to be significantly more common in pa-
tients with otorrhea after routine pneumococcal vaccina-
tion in the United States.6 We therefore considered S.
aureus as a possible pathogen for AOM with otorrhea and
enrolled these patients for further analysis.
Chiu et al8 reported the epidemiology andmicrobiology in
pediatric patients with culture-proven AOM in Taiwan be-
tween 1999 and 2008, and the most common pathogens of
spontaneous otorrhea were S. pneumoniae (65.9%), non-
typeable H. influenzae (18.6%), and S. pyogenes (6.2%). Our
result also showed a similar percentage of S. pneumoniae.
After the introduction of PCV, H. influenzae became more
prevalent in AOM; by contrast, the incidence of S. pneumo-
niae infection became less.21 PCV has been introduced in
Taiwan since October 2005, but not yet included in the Na-
tional Immunization Program; therefore, the change in
microbiology of AOM needs further observation.
AOM caused by S. pyogenes is characterized by older age
with higher rates of tympanic perforation and mastoiditis in
children.15,22 S. pyogenes accounted for 5.7e29% of all
pathogens in spontaneous otorrhea.13,15 In this study, only
two patients (3.8%) were found to have S. pyogenes infec-
tion, with one of them having mastoiditis. The lower rate of
S. pyogenes infection and higher morbidity are compatible
with the results of previous studies.13,15
We also analyzed the serotype distribution of pneumo-
coccal isolates from patients with otorrhea. Serotype 19A
accounted for two-thirds of the isolates available. After the
wide use of PCV7, 19A became the major cause of invasive
pneumococcal disease (IPD) in the world.23e25 Emergence
of multidrug-resistant serotype 19A was reported in Korea
and Israel prior to the introduction of PCV7, suggesting that
the capsular switch driven by PCV7 was not the only reason
for the emergence of 19A.26,27 PCV-related serotype
replacement, antibiotic selection pressure, and genetic
changes in S. pneumoniae lead to the rise of serotype 19A
globally.26e28 In Taiwan, serotype 19A has been noted as an
emerging serotype and has become the most prevalent
cause for IPD since 2009 (affecting 43.4% of children 5
years in 2011) (data from Taiwan Center for Disease Con-
trol). The emergence of serotype 19A in Taiwan is similar to
that in Korea because of high antibiotic selective pressure
and suboptimal vaccine coverage.29 In addition to causing
IPD, serotype 19A has been reported as the main serotype
of S. pneumoniae in AOM in the post-PCV7 era.21,23,30,31 In
one study on the epidemiology of spontaneous otorrhea
after PCV7 in Greece, the proportion of serotype 19A iso-
lates increased from 2% in 2006 to 25% in 2008.15 Serotype
19A appears to have higher AOM potential than other non-
vaccine serotypes.32 Children with AOM also have a higher
risk of 19A nasopharyngeal colonization, as reported in a
national study in France.33 These studies indicate the
prominence and importance of serotype 19A not only in
IPD, but also in AOM and nasopharyngeal colonization.
Serotype 19A is known to show a high level of antimi-
crobial resistance. In this study, the nonsusceptible rates of
pneumococcal 19A isolates were observed to be 66.6% to
Table 4 Comparison of clinical manifestations between patients with pneumococcal infection and others
Pneumococcal group
(n Z 29)
Nonpneumococcal group
(n Z 18)
p
Symptoms and signs
Fever 29 (100) 11 (61.1) 0.001
Highest temperature (C) 39.31  0.69 39.07  0.73 0.354
Fever 39C 20 (69.0) 7 (38.9) 1.000
Fever duration (d) 6.03  3.24 5.91  4.37 0.921
Otorrhea onset day following fever (d) 3.97  3.61 4  4.65 0.980
Ear pain/ear rubbing 18 (62.1) 6 (33.3) 0.055
Cough 26 (89.7) 11 (61.1) 0.030
Rhinorrhea/nasal obstruction 25 (86.2) 8 (44.4) 0.002
Nausea/vomiting 1 (3.4) 1 (5.6) 1.000
Diarrhea 2 (6.9) 2 (11.1) 0.631
Bilateral otorrhea 13 (44.8) 1 (5.6) 0.004
Laboratory test
Peak WBC (1000/mL) 13.93  5.67 14.46  3.94 0.730
Leukocytosis (WBC 15,000) 11 (37.9) 6 (33.3) 0.750
Peak CRP (mg/L) 71.92  63.26 33.98  38.16 0.015
High CRP (>50 mg/L) 14 (48.3) 4 (23.5) 0.097
Associated diagnosis
Upper respiratory tract 4 0
Flu/flu-like illness 3 0
Sinusitis 4 1
Lower respiratory tracta 5 3
Acute gastroenteritis 2 2
Outcome
Complicationsb 1 (3.4) 3 (16.7) 0.150
Hospitalization duration (d) 5.28  2.31 4.33  2.64 0.200
a Lobar pneumonia and necrotizing pneumonia have been excluded.
b Complications in pneumococcal group: one bacteremia; complications in nonpneumococcal group: two mastoiditis and one peri-
auricular cellulitis.
Data are presented as n (%) or mean  SD.
CRP Z C-reactive protein; SD Z standard deviation; WBC Z white blood cell.
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criteria. The antibiotic resistance of S. pneumoniae in
Taiwan has increased gradually in recent years. Non-
susceptibility to ceftriaxone among invasive isolates has
increased significantly since 2005, reaching 76.4% by the
meningitis criteria and 21.3% by the nonmeningitis criteria
in 2007 among invasive isolates from children aged 2e4
years.29,34 An analysis of the drug susceptibility of pneu-
mococcal 19A isolates from children with IPD during
2005e2007 in Taiwan revealed that 78% of S. pneumoniae
were nonsusceptible to penicillin by nonmeningitis criteria.
ST320 accounted for the majority of these 19A isolates.35 In
Taiwan and some Asian countries, the high prevalence of
multidrug-resistant ST320 may explain the high non-
susceptibility rate of 19A.36 The higher nonsusceptibility
rate in this study may explain why the patients with AOM
progressed to spontaneous otorrhea despite initial antimi-
crobial therapy in local medical offices.
This study has certain limitations. This is a retrospective
study, and therefore not all patients with spontaneous
otorrhea had pus cultures. Only 75.4% of them were culture
positive. The possible explanations for negative culture in
some patients include previous antibiotic exposure, viral
infection only, and lower number of bacteria present in the
specimens. It is also difficult to address the treatment issuebecause of the retrospective nature of this study.
Furthermore, the way to obtain cultures from external
auditory canal was simple and useful, but some of the
pathogens might still have been missed.20
In conclusion, S. pneumoniae remained the most com-
mon etiologic agent responsible for AOM with spontaneous
otorrhea. Serotype 19A was the most common serotype for
AOM with otorrhea in Taiwan, where PCV has been used
only in the private sector. S. pneumoniae, serotype 19A in
particular, was also observed to exhibit high non-
susceptibility to penicillin and ceftriaxone. Because it is
difficult to perform tympanocentesis in children, sterile
swab sampling for spontaneous otorrhea is an alternative
way to know the etiology of severe AOM, which can be used
to guide the treatment.References
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